About: http://hub.abes.fr/oup/periodical/annonc/2010/volume_21/issue_9/w

Documentation

scienceplus.abes.fr version Bêta

scienceplus.abes.fr | explorer

À propos de : http://hub.abes.fr/oup/periodical/annonc/2010/volume_21/issue_9/w Goto Sponge NotDistinct Permalink

Attributs	Valeurs
type	work Issue
Is Part Of	http://hub.abes.fr/oup/periodical/annonc/2010/volume_21
has manifestation of work	http://hub.abes.fr/oup/periodical/annonc/2010/volume_21/issue_9/m/print http://hub.abes.fr/oup/periodical/annonc/2010/volume_21/issue_9/m/web
Date Copyrighted	2010
Rights	© The Author 2010. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org © The Author 2010. Published by Oxford University Press on behalf of the European Society for Medical Oncology.
issue	9
Access Rights	creative-commons
is Is Part Of of	Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy Adjuvant chemotherapy in rectal cancer—an issue or a nonissue? Effect of addition of rituximab to salvage chemotherapy on outcome of patients with diffuse large B-cell lymphoma relapsing after an autologous stem-cell transplantation Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE) ERCC1 and histopathology in advanced NSCLC patients randomized in a large multicenter phase III trial Does adjuvant fluoropyrimidine-based chemotherapy provide a benefit for patients with resected rectal cancer who have already received neoadjuvant radiochemotherapy? A systematic review of randomised trials All circulating EpCAM+CK+CD45− objects predict overall survival in castration-resistant prostate cancer A prognostic model in patients treated for metastatic gastric cancer with second-line chemotherapy The expression of p38, ERK1 and Bax proteins has increased during the treatment of newly diagnosed acute promyelocytic leukemia with arsenic trioxide Sunitinib-induced reduction in skin microvascular density is a reversible phenomenon Severe rhabdomyolysis during sunitinib treatment of metastatic renal cell carcinoma. A report of two cases Communication about high-cost drugs in oncology—the patient view Enhancing activity and overcoming chemoresistance in hematologic malignancies with bortezomib: preclinical mechanistic studies Overall survival with cisplatin-gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL) Outcome analysis of patients with transformed teratoma to primitive neuroectodermal tumor Change in lung tumor volume as a biomarker of treatment response: a critical review of the evidence Cancer profile in Eastern Libya: incidence and mortality in the year 2004 FDG-PET in the assessment of patients with follicular lymphoma treated by ibritumomab tiuxetan Y 90: multicentric study Chemotherapy of advanced small-bowel adenocarcinoma: a multicenter AGEO study From randomized trial to practice: single institution experience using the GOG 172 i.p. chemotherapy regimen for ovarian cancer Results of a phase I/II study of ocrelizumab, a fully humanized anti-CD20 mAb, in patients with relapsed/refractory follicular lymphoma A multicenter international randomized phase III study comparing cisplatin in combination with irinotecan or etoposide in previously untreated small-cell lung cancer patients with extensive disease In this issue Long-term follow-up after risk-adapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy. A SWENOTECA study Urinary N-telopeptide (uNTx) is an independent prognostic factor for overall survival in patients with bone metastases from castration-resistant prostate cancer Targeted agents in metastatic Xp11 translocation/TFE3 gene fusion renal cell carcinoma (RCC): a report from the Juvenile RCC Network Cardiac toxicity in association with chemotherapy and radiation therapy in a large cohort of older patients with non-small-cell lung cancer A 3-day short course of palifermin before HDT reduces toxicity and need for supportive care after autologous blood stem-cell transplantation in patients with multiple myeloma Misrepresentation Need for a new trial to evaluate postoperative radiotherapy in renal cell carcinoma: a meta-analysis of randomized controlled trials Clinical outcome of leiomyosarcomas of vascular origin: comparison with leiomyosarcomas of other origin ‘A no means no’—measuring depression using a single-item question versus Hospital Anxiety and Depression Scale (HADS-D)

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata